Admission to Trading
In brief · summary, not quotable
Oxford Biomedica PLC has announced the admission of 5,654 ordinary shares to trading on the London Stock Exchange's Main Market, pursuant to its Long Term Incentive Plan. These new shares, which are fungible with existing ordinary shares of 50p each, bring the total number of shares admitted to trading to 121,050,158. This admission covers shares allotted between August 12, 2026, and October 2, 2026.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
| Issuer name: | OXFORD BIOMEDICA PLC |
|---|---|
| Issuer LEI: | 213800S1GVQNXQ15K851 |
| Name, type and ISIN of the shares: | Ordinary shares of 50p each GB00BDFBVT43 |
| Number of further shares admitted to trading covered by the notification: | 5,654 |
| Total number of shares admitted to trading (including the new shares): | 121,050,158 |
| Date range covered by the notification: | 12 August 2026 – 2 October 2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.